Cell-associated HIV-1 RNA in blood as indicator of virus load in lymph nodes

Journal of Infectious Diseases

Volumn 180, Issue 3, 1999, Pages 850-853

  Yerly, S ^a   Rutschmann, O T ^a   Opravil, M ^b   Marchal, F ^a   Hirschel, B ^a   Perrin, Luc ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; DIDANOSINE; HYDROXYUREA; STAVUDINE; VIRUS RNA;

ANTIBIOTIC THERAPY; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE MARKER; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; LYMPH NODE BIOPSY; NONHUMAN; PREDICTION; PRIORITY JOURNAL; TREATMENT OUTCOME; VIREMIA; VIRUS LOAD;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ANTI-HIV AGENTS; CD4-CD8 RATIO; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; DIDANOSINE; DRUG THERAPY, COMBINATION; HIV INFECTIONS; HIV-1; HUMANS; HYDROXYUREA; LYMPH NODES; RNA, VIRAL; STAVUDINE; VIRAL LOAD;

EID: 0032825560     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/314932     Document Type: Article

References (15)

1. 1. Pantaleo G, Graziosi C, Butini L, et al. Lymphoid organs function as major reservoirs for human immunodeficiency virus. Proc Natl Acad Sci USA 1991;88:9838-42.
2. 2. Perrin L, Yerly S, Marchal F, et al. Viral burden in lymph nodes and blood of subjects with primary human immunodeficiency virus type 1 infection on bitherapy. J Infect Dis 1998;177:1497-501.
3. 3. Wong JK, Gunthard HF, Havlir DV, et al. Reduction of HIV-1 in blood and lymph nodes following potent antiretroviral therapy and the virologic correlates of treatment failure. Proc Natl Acad Sci USA 1997;94:12574-9.
4. 4. Lafeuillade A, Chollet L, Hittinger G, Profizi N, Costes O, Poggi C. Residual human immunodeficiency virus type 1 RNA in lymphoid tissue of patients with sustained plasma RNA of <200 copies/mL. J Infect Dis 1998;177: 235-8.
5. 5. Haase AT, Henry K, Zupancic M, et al. Quantitative image analysis of HIV-1 infection in lymphoid tissue. Science 1996;274:985-9.
6. 6. Cavert W, Notermans DW, Staskus K, et al. Kinetics of response in lymphoid tissues to antiretroviral therapy of HIV-1 infection. Science 1997;276: 960-4.
7. 7. Notermans DW, Jurriaans S, de Wolf F, et al. Decrease of HIV-1 RNA levels in lymphoid tissue and peripheral blood during treatment with ritonavir, lamivudine and zidovudine. AIDS 1998;12:167-73.
8. 8. Meylan PR, Burgisser P, Weyrich-Suter C, Spertini F. viral load and immunophenotype of cells obtained from lymph nodes by fine needle aspiration as compared with peripheral blood cells in HIV-infected patients. J Acquir Immune Defic Syndr Hum Retrovirol 1996;13:39-47.
9. 9. Rutschmann O, Opravil M, Iten A, et al. A placebo-controlled trial of didanosine plus stavudine, with and without hydroxyurea, for HIV infection. AIDS 1998;12:F71-7.
10. 10. Schockmel G, Yerly S, Perrin L. Detection of low HIV-1 RNA levels in plasma. J Acquir Immune Defic Syndr Hum Retrovirol 1997;14:179-83.
11. 11. McHomey CA, Ware JE, Raczek AE. The MOS 36-Item Short-Form Health Survey (SF-36): II. Psychometric and clinical tests of validity in measuring physical and mental health construct. Med Care 1993;31:247-63.
12. 12. Montaner JSG, Zala C, Conway B, et al. A pilot study of hydroxyurea among patients with advanced human immunodeficiency virus (HIV) disease receiving chronic didanosine therapy: Canadian HIV Trials Network Protocol 088. J Infect Dis 1997;175:801-6.
13. 13. Wong JK, Hezareh M, Günthard HF, et al. Recovery of replication-competent HIV despite prolonged suppression of plasma viremia. Science 1997;278:1291-5.
14. 14. Andersson J, Racz P, Tenner-Racz, et al. Defect in cytolytic effector molecules in lymphoid tissue during primary HIV-1 infection is a very early mechanism of immune dysfunction [abstract LB3b]. In: Program and abstracts of the 6th Conference on Retroviruses and Opportunistic Infections (Chicago). Alexandria, Virginia: Foundation for Retrovirology and Human Health, 1999:205.
15. 15. Perelson AS, Neumann AU, Markowitz M, Leonard JM, Ho DD. HIV-1 dynamics in vivo: virion clearance rate, infected cell life-span, and viral generation time. Science 1996;271:1582-6.